741 institutions hold shares in Catalent Inc. (CTLT), with 956.67k shares held by insiders accounting for 0.56% while institutional investors hold 103.15% of the company’s shares. The shares outstanding are 170.23M, and float is at 169.45M with Short Float at 1.61%. Institutions hold 102.57% of the Float.
The top institutional shareholder in the company is Price (T.Rowe) Associates Inc with over 20.35 million shares valued at $2.12 billion. The investor’s holdings represent 11.96% of the CTLT Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 17.47 million shares valued at $1.82 billion to account for 10.26% of the shares outstanding. The other top investors are Blackrock Inc. which holds 13.29 million shares representing 7.81% and valued at over $1.38 billion, while Janus Henderson Group PLC holds 7.02% of the shares totaling 11.95 million with a market value of $1.24 billion.
Catalent Inc. (NYSE: CTLT) is 9.46% higher on its value in year-to-date trading and has touched a low of $65.00 and a high of $127.68 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CTLT stock was last observed hovering at around $113.22 in the last trading session, with the day’s gains setting it 0.7% off its average median price target of $137.00 for the next 12 months. It is also 19.77% off the consensus price target high of $142.00 offered by 13 analysts, but current levels are 5.07% higher than the price target low of $120.00 for the same period.
Currently trading at $113.92, the stock is 3.73% and 4.60% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.87 million and changing 0.62% at the moment leaves the stock 14.46% off its SMA200. CTLT registered 65.37% gain for a year compared to 6-month gain of 24.52%. The firm has a 50-day simple moving average (SMA 50) of $107.83 and a 200-day simple moving average (SMA200) of $105.61.
The stock witnessed a 9.99% loss in the last 1 month and extending the period to 3 months gives it a -0.84%, and is 0.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.11% over the week and 2.14% over the month.
Catalent Inc. (CTLT) has around 13900 employees, a market worth around $19.11B and $3.46B in sales. Current P/E ratio is 64.07 and Fwd P/E is 34.81. Profit margin for the company is 8.40%. Distance from 52-week low is 75.26% and -10.78% from its 52-week high. The company has generated returns on investments over the last 12 months (5.70%).
Catalent Inc. (CTLT) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Catalent Inc. (CTLT) is a “Buy”. 13 analysts offering their recommendations for the stock have an average rating of 1.70, where 2 rate it as a Hold and 1 think it is a “Overweight”. 10 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Catalent Inc. is expected to release its quarterly report on 08/30/2021 and quarterly earnings per share for the current quarter are estimated at $0.74 with sales reaching $993.2M over the same period.The EPS is expected to grow by 20.60% this year, but quarterly earnings will post 25.90% year-over-year. Quarterly sales are estimated to grow 30.60% in year-over-year returns.
Catalent Inc. (CTLT) Insider Activity
A total of 42 insider transactions have happened at Catalent Inc. (CTLT) in the last six months, with sales accounting for 31 and purchases happening 11 times. The most recent transaction is an insider sale by Schmidt Kay A, the company’s SVP, Technical Operations. SEC filings show that Schmidt Kay A sold 1,400 shares of the company’s common stock on Mar 22 at a price of $105.77 per share for a total of $0.15 million. Following the sale, the insider now owns 13866.0 shares.
Catalent Inc. disclosed in a document filed with the SEC on Mar 19 that Chiminski John R (Chair & CEO) sold a total of 183,024 shares of the company’s common stock. The trade occurred on Mar 19 and was made at $106.01 per share for $19.4 million. Following the transaction, the insider now directly holds 0.16 million shares of the CTLT stock.
Still, SEC filings show that on Mar 18, Chiminski John R (Chair & CEO) disposed off 42,220 shares at an average price of $105.16 for $4.44 million. The insider now directly holds 163,618 shares of Catalent Inc. (CTLT).
Catalent Inc. (CTLT): Who are the competitors?
The company’s main competitors (and peers) include Aerie Pharmaceuticals Inc. (AERI) that is trading 13.23% up over the past 12 months. Supernus Pharmaceuticals Inc. (SUPN) is 32.67% up on the 1-year trading charts. Short interest in the company’s stock has fallen -16.67% from the last report on Apr 14, 2021 to stand at a total of 2.73 million short shares sold with a short interest ratio of 2.35.